RISPOVAL RS

Šalis: Airija

kalba: anglų

Šaltinis: HPRA (Health Products Regulatory Authority)

Veiklioji medžiaga:

Live attenuated bovine respiratory syncytial virus; strain rb94

Prieinama:

Zoetis Belgium S.A.

ATC kodas:

QI02AD04

INN (Tarptautinis Pavadinimas):

Live attenuated bovine respiratory syncytial virus; strain rb94

Dozė:

.

Vaisto forma:

Powder for suspension for injection

Recepto tipas:

POM (E): Prescription Only Exempt as defined in relevant national legislation

Farmakoterapinė grupė:

Cattle

Gydymo sritis:

bovine respiratory syncytial virus (BRSV)

Terapinės indikacijos:

Immunological - Live Vaccine

Autorizacija statusas:

Authorised

Leidimo data:

2014-07-11

Prekės savybės

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
RISPOVAL RS
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dose of Rispoval RS contains the following :
ACTIVE INGREDIENT(S)
Live attenuated Bovine Respiratory Syncytial Virus, strain RB94 :
minimum :10
CCID
per dose.
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Powder for suspension for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle and calves from 7 days of age.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
RISPOVAL RS is a live attenuated vaccine designed to reduce the
respiratory symptoms caused by Bovine Respiratory
Syncytial Virus in cattle.
Use of the vaccine results in a reduction in viral shedding.
Duration of immunity is 4 months.
4.3 CONTRAINDICATIONS
None.
5.5
50
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_0_
_/_
_0_
_3_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_5_
_3_
_9_
_6_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Do not vaccinate animals for at least one month after cessation of
corticosteroid treatment. The presence of maternally
derived antibodies may affect the efficacy of Rispoval RS. When
vaccinating calves of less than 4 months of age, an
extra injection is required (see Section 4.9).
Unhealthy animals should not be vaccinated.
Maximum protection occurs when the whole herd is vaccinated.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None.